Related Experiment Video
Updated: Jun 3, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Endothelial Cpt1a Inhibits Neonatal Hyperoxia-Induced Pulmonary Vascular Remodeling by Repressing
Xiaoyun Li1,2,3,4, Katy Hegarty1, Fanjie Lin5
1Department of Molecular Biology, Cellular Biology, and Biochemistry, Brown University, Providence, RI, 02912, USA.
Neonatal hyperoxia causes pulmonary hypertension (PH) in infants by reducing endothelial carnitine palmitoyltransferase 1a (Cpt1a) and increasing endothelial-mesenchymal transition (EndoMT). Targeting Cpt1a or EndoMT may treat BPD-associated PH.
Area of Science:
- Neonatal physiology
- Pulmonary vascular disease
- Cellular metabolism
Background:
- Bronchopulmonary dysplasia (BPD) in preterm infants is linked to increased mortality from pulmonary hypertension (PH).
- Current therapies for BPD-associated PH are limited, highlighting the need for novel treatment strategies.
- Endothelial carnitine palmitoyltransferase 1a (Cpt1a) plays a crucial role in cellular metabolism, but its function in neonatal PH and BPD is not well understood.
Purpose of the Study:
- To investigate the role of endothelial Cpt1a in the development of PH and pulmonary vascular remodeling in a neonatal hyperoxia model.
- To determine if Cpt1a reduction contributes to endothelial-mesenchymal transition (EndoMT) in the context of hyperoxia-induced lung injury.
- To explore potential therapeutic targets for BPD-associated PH by modulating Cpt1a levels or inhibiting EndoMT.
Main Methods:
- Utilized endothelial cell-specific Cpt1a knockout (KO) and wild-type (WT) mice exposed to hyperoxia (70% O2) from <12 hours old for 14 days, followed by recovery in normoxia.
- Assessed pulmonary hypertension (PH) and pulmonary vascular (PV) remodeling using physiological measurements and histological analyses.
- Investigated endothelial-mesenchymal transition (EndoMT) through immunofluorescence, single-cell RNA sequencing (scRNA-seq), and EC lineage tracing.
Main Results:
- Hyperoxia induced PH, which was exacerbated in EC-specific Cpt1a KO mice compared to WT controls.
- Upregulating endothelial Cpt1a expression attenuated hyperoxia-induced PV remodeling.
- Hyperoxia promoted lung EndoMT, and this process was further enhanced in EC-specific Cpt1a KO mice; blocking EndoMT ameliorated PV remodeling.
- Male mice exhibited more severe PH than females, correlating with reduced endothelial Cpt1a expression.
Conclusions:
- Neonatal hyperoxia causes PH and PV remodeling by decreasing endothelial Cpt1a expression and promoting EndoMT.
- Endothelial Cpt1a deficiency aggravates hyperoxia-induced PH and PV remodeling.
- Targeting endothelial Cpt1a upregulation or EndoMT inhibition presents a promising therapeutic strategy for BPD-associated PH.
More Related Videos
08:38Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...